1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. DRUG AND ALCOHOL SCREENING MARKET BY SAMPLE TYPE
5.1. Urine
5.2. Breath
5.3. Oral Fluid
5.4. Blood
5.5. Others
6. DRUG AND ALCOHOL SCREENING MARKET BY END-USER
6.1. Hospitals and Treatment Facilities
6.2. Law and Enforcement
6.3. Sporting Events
6.4. Others
7. DRUG AND ALCOHOL SCREENING MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. UAE
7.4.2. Israel
7.4.3. Saudi Arabia
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Positioning Matrix and Ranking
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Abbott
9.2. Premier Biotech, Inc.
9.3. Drägerwerk AG & Co.
9.4. OraSure Technologies Inc.
9.5. Alfa Scientific Designs, Inc.
9.6. Lifeloc Technologies Inc.
9.7. Express Diagnostics Int’l
9.8. F. Hoffmann-La Roche Ltd
9.9. Shimadzu Corporation
9.10. Siemens Healthineers